2026-06-02

SOL open interest +244.9% - OI surge

ETH open interest +185.4% - OI surge

BTC open interest -35.5% - OI collapse

BTC ETF inflow of $2607M - institutional buying

ETH open interest -65.0% - OI collapse

SOL open interest -56.1% - OI collapse

BTC open interest -46.1% - OI collapse

BTC ETF inflow of $2607M - institutional buying

SOL open interest +231.5% - OI surge

BTC open interest -45.8% - OI collapse

ETH open interest -64.5% - OI collapse

ETH open interest -65.2% - OI collapse

SOL open interest -58.9% - OI collapse

BTC open interest -45.4% - OI collapse

SOL funding rate -0.0201% - SHORT SQUEEZE SETUP

SOL RSI 25.9 - oversold (crossed below 30)

ETH DEX volume/liquidity ratio elevated (0.64x) - strong on-chain trading activity

SOL DEX volume/liquidity ratio elevated (1.20x) - strong on-chain trading activity

ETH RSI 24.6 - oversold (crossed below 30)

SOL RSI 29.0 - oversold (crossed below 30)

ETH RSI 29.4 - oversold (crossed below 30)

OSINT: S&P 500 hits record high, eyes 10‑week winning streak

Saudi Arabia (Dhahran): drought conditions detected - potential oil supply impact

OSINT: Iran Delays Response to US Draft Sanctions, Market Awaits Outcome

Saudi Arabia (Dhahran): drought conditions detected - potential oil supply impact

Oil +1.71% - significant rally

Gold +1.06% - significant rally

Oil -1.20% - significant selloff

Gold +1.86% - significant rally

FDA approves ZURZUVAE (BIOGEN) - new revenue stream

FDA approves TECFIDERA (BIOGEN) - new revenue stream

FDA approves VUMERITY (BIOGEN) - new revenue stream

FDA approves TECFIDERA (BIOGEN) - new revenue stream

FDA approves VUMERITY (BIOGEN) - new revenue stream

FDA approves ZURZUVAE (BIOGEN) - new revenue stream

FDA approves ZURZUVAE (BIOGEN) - new revenue stream

FDA approves VUMERITY (BIOGEN) - new revenue stream

FDA approves TECFIDERA (BIOGEN) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

SPY RSI 71.2 - overbought (crossed above 70)

QQQ RSI 75.2 - overbought (crossed above 70)

SPY RSI 70.2 - overbought (crossed above 70)

QQQ RSI 71.9 - overbought (crossed above 70)

Q1-2026: Beat consensus by 24.6% - EPS $1.15 vs $0.9229 estimate

Q3-2026: Beat consensus by 80.2% - EPS $-0.01 vs $-0.0505 estimate

Q1-2026: Missed consensus by 3280.3% - EPS $-8.16 vs $-0.2414 estimate

Q2-2025: Missed consensus by 1109.2% - EPS $-0.74 vs $-0.0612 estimate

Q3-2025: Missed consensus by 250.1% - EPS $-0.25 vs $-0.0714 estimate

Q4-2025: Missed consensus by 218.6% - EPS $-0.26 vs $-0.0816 estimate

Q4-2014: Missed consensus by 67.3% - EPS $0.07 vs $0.2142 estimate

Q1-2026: Beat consensus by 65.6% - EPS $0.29 vs $0.1751 estimate

Q2-2025: Beat consensus by 22.7% - EPS $0.32 vs $0.2609 estimate

Q3-2025: Beat consensus by 20.0% - EPS $0.34 vs $0.2833 estimate

Q2-2025: Missed consensus by 6.9% - EPS $0.22 vs $0.2362 estimate

Q4-2025: Missed consensus by 20.8% - EPS $0.2 vs $0.2524 estimate

Q3-2025: Missed consensus by 9.6% - EPS $0.24 vs $0.2655 estimate

Q1-2026: Beat consensus by 117.6% - EPS $0.62 vs $0.2849 estimate

Q4-2026: Beat consensus by 39.3% - EPS $0.8 vs $0.5743 estimate

Q2-2026: Beat consensus by 55.4% - EPS $1.47 vs $0.9458 estimate

Q3-2026: Beat consensus by 45.8% - EPS $1.24 vs $0.8503 estimate

Q4-2025: Missed consensus by 71.5% - EPS $0.03 vs $0.1054 estimate

Missed consensus by 44.4% - EPS $0.07 vs $0.126 estimate

Q2-2026: Missed consensus by 80.4% - EPS $0.03 vs $0.1531 estimate

Q1-2024: Missed consensus by 210.9% - EPS $-2.6 vs $-0.8364 estimate

Beat consensus by 41.2% - EPS $-0.06 vs $-0.102 estimate

Q3-2024: Beat consensus by 94.6% - EPS $-0.01 vs $-0.1836 estimate

Q2-2024: Beat consensus by 130.8% - EPS $0.16 vs $-0.5202 estimate

Q2-2025: Beat consensus by 7.6% - EPS $1.15 vs $1.0691 estimate

Missed consensus by 78.4% - EPS $-0.61 vs $-0.342 estimate

Q2-2025: Missed consensus by 214.7% - EPS $-0.35 vs $-0.1112 estimate

Q4-2025: Missed consensus by 32.6% - EPS $-0.93 vs $-0.7014 estimate

Q1-2026: Beat consensus by 91.1% - EPS $-0.066 vs $-0.7457 estimate

Q1-2026: Missed consensus by 65.1% - EPS $-1.28 vs $-0.7752 estimate

Q3-2025: Beat consensus by 46.5% - EPS $-2.64 vs $-4.9368 estimate

Q2-2025: Missed consensus by 27.7% - EPS $-5 vs $-3.9168 estimate

Q4-2025: Missed consensus by 9.2% - EPS $0.72 vs $0.7929 estimate

Q1-2026: Beat consensus by 22.1% - EPS $1.04 vs $0.8518 estimate

Q2-2025: Missed consensus by 88.7% - EPS $0.02 vs $0.1768 estimate

Q1-2026: Missed consensus by 69.6% - EPS $0.02 vs $0.0657 estimate

Q4-2025: Missed consensus by 265.0% - EPS $-0.15 vs $0.0909 estimate

Q3-2025: Beat consensus by 60.9% - EPS $0.26 vs $0.1616 estimate

Q3-2000: Beat consensus by 31.8% - EPS $-0.31 vs $-0.4545 estimate

Q2-2000: Missed consensus by 31.5% - EPS $-0.31 vs $-0.2357 estimate

Q1-2026: Missed consensus by 10.0% - EPS $1.91 vs $2.1214 estimate

Q3-2022: Beat consensus by 253.5% - EPS $4.5 vs $-2.9325 estimate

Beat consensus by 74.0% - EPS $-0.53 vs $-2.04 estimate

Q1-2026: Missed consensus by 149.6% - EPS $-0.28 vs $-0.1122 estimate

Q2-2026: Beat consensus by 36.1% - EPS $1.36 vs $0.9989 estimate

Q1-2026: Missed consensus by 6.8% - EPS $0.77 vs $0.8264 estimate

Missed consensus by 64.6% - EPS $0.18 vs $0.508 estimate

Q1-2026: Beat consensus by 13.1% - EPS $-0.43 vs $-0.4949 estimate

Q2-2025: Beat consensus by 5.4% - EPS $0.69 vs $0.6545 estimate

Q3-2025: Beat consensus by 15.2% - EPS $0.86 vs $0.7463 estimate

Q4-2025: Beat consensus by 8.2% - EPS $1.39 vs $1.2852 estimate

Q4-2025: Missed consensus by 66.2% - EPS $0.05 vs $0.1481 estimate

Q1-2026: Beat consensus by 87.0% - EPS $0.17 vs $0.0909 estimate

Q1-2026: Beat consensus by 31.7% - EPS $1.55 vs $1.1767 estimate

Beat consensus by 35.4% - EPS $-8.5 vs $-13.158 estimate

Missed consensus by 22.5% - EPS $-14 vs $-11.424 estimate

Missed consensus by 17.6% - EPS $-4.32 vs $-3.672 estimate

Beat consensus by 17.0% - EPS $-2.88 vs $-3.468 estimate

Q1-2026: Missed consensus by 82.3% - EPS $-0.53 vs $-0.2907 estimate

Q3-2025: Missed consensus by 8.3% - EPS $1.44 vs $1.5708 estimate

Q2-2025: Missed consensus by 17.6% - EPS $0.37 vs $0.4488 estimate

Q2-2025: Beat consensus by 12.0% - EPS $-0.08 vs $-0.0909 estimate

Q3-2025: Beat consensus by 20.0% - EPS $-0.07 vs $-0.0875 estimate

Q1-2026: Beat consensus by 9.6% - EPS $-0.07 vs $-0.0774 estimate

Q1-2026: Beat consensus by 61.2% - EPS $-0.03 vs $-0.0774 estimate

Q3-2025: Beat consensus by 10.0% - EPS $-0.06 vs $-0.0667 estimate

Q4-2025: Beat consensus by 23.9% - EPS $-0.05 vs $-0.0657 estimate

Q2-2025: Beat consensus by 15.9% - EPS $-0.07 vs $-0.0832 estimate

Q1-2026: Missed consensus by 21.3% - EPS $0.32 vs $0.4066 estimate

Q1-2026: Beat consensus by 20.3% - EPS $-0.26 vs $-0.3264 estimate

Q2-2026: Beat consensus by 21.4% - EPS $0.26 vs $0.2142 estimate

Beat consensus by 137.4% - EPS $0.07 vs $-0.187 estimate

Q2-2026: Beat consensus by 10.3% - EPS $0.22 vs $0.1995 estimate

Q4-2025: Beat consensus by 40.6% - EPS $-0.03 vs $-0.0505 estimate

Q1-2026: Missed consensus by 77.2% - EPS $0.03 vs $0.1313 estimate

Q3-2025: Beat consensus by 321.0% - EPS $0.45 vs $0.1069 estimate

Q3-2025: Beat consensus by 759.2% - EPS $0.47 vs $0.0547 estimate

Q1-2026: Missed consensus by 14.9% - EPS $0.59 vs $0.6936 estimate

Beat consensus by 10.3% - EPS $0.8 vs $0.725 estimate

Q2-2025: Beat consensus by 80.8% - EPS $-0.09 vs $-0.4681 estimate

Q4-2007: Beat consensus by 32.1% - EPS $-6 vs $-8.8401 estimate

Q3-2025: Missed consensus by 83.2% - EPS $-1.14 vs $-0.6222 estimate

Beat consensus by 80.4% - EPS $-0.01 vs $-0.051 estimate

Q3-2025: Missed consensus by 607.7% - EPS $-1.39 vs $-0.1964 estimate

Q4-2025: Missed consensus by 2078.6% - EPS $-4 vs $-0.1836 estimate

Q2-2025: Beat consensus by 30.4% - EPS $-0.19 vs $-0.2729 estimate

Q1-2026: Missed consensus by 22.8% - EPS $-0.52 vs $-0.4233 estimate

Q1-2026: Beat consensus by 35.6% - EPS $1.54 vs $1.1358 estimate

Q2-2000: Beat consensus by 5.0% - EPS $0.24333 vs $0.2317 estimate

Q4-2025: Beat consensus by 19.7% - EPS $1.12 vs $0.9358 estimate

Q4-2025: Missed consensus by 369.0% - EPS $-1.07 vs $0.3978 estimate

Beat consensus by 92.5% - EPS $-0.1 vs $-1.326 estimate

Q1-2026: Beat consensus by 30.2% - EPS $-1.31 vs $-1.8768 estimate

Missed consensus by 161.4% - EPS $-1.32 vs $-0.505 estimate

Q1-2026: Missed consensus by 67.3% - EPS $-1.2 vs $-0.7171 estimate

Q4-2025: Beat consensus by 16.8% - EPS $0.082 vs $0.0702 estimate

Q2-2024: Beat consensus by 9.1% - EPS $0.068 vs $0.0623 estimate

Q2-2025: Beat consensus by 15.2% - EPS $0.075 vs $0.0651 estimate

Q4-2024: Beat consensus by 24.1% - EPS $0.082 vs $0.0661 estimate

Q4-2025: Missed consensus by 185.0% - EPS $-9.44 vs $-3.3128 estimate

Q1-2026: Beat consensus by 15.9% - EPS $-1.77 vs $-2.1058 estimate

Q3-2025: Beat consensus by 18.5% - EPS $-27.6 vs $-33.8754 estimate

Beat consensus by 42.6% - EPS $-54.24 vs $-94.536 estimate

Q3-2025: Beat consensus by 19.3% - EPS $-0.14 vs $-0.1734 estimate

Q4-2025: Beat consensus by 14.2% - EPS $-0.14 vs $-0.1632 estimate

Q1-2026: Beat consensus by 54.8% - EPS $-0.06 vs $-0.1326 estimate

Q4-2025: Beat consensus by 812.9% - EPS $0.38 vs $-0.0533 estimate

Q2-2025: Beat consensus by 579.0% - EPS $1.07 vs $-0.2234 estimate

Q1-2026: Missed consensus by 32.0% - EPS $-0.12 vs $-0.0909 estimate

Q2-2025: Missed consensus by 63.4% - EPS $-0.11 vs $-0.0673 estimate

Q4-2025: Missed consensus by 48.6% - EPS $-0.13 vs $-0.0875 estimate

Q4-2025: Missed consensus by 17.3% - EPS $0.134 vs $0.1621 estimate

Q2-2025: Missed consensus by 24.5% - EPS $0.12397 vs $0.1641 estimate

Q4-2025: Missed consensus by 7.7% - EPS $3.732 vs $4.0445 estimate

Missed consensus by 11.2% - EPS $2.96 vs $3.333 estimate

Q4-2024: Beat consensus by 5.1% - EPS $3.152 vs $2.9997 estimate

Beat consensus by 31.6% - EPS $42.528 vs $32.32 estimate

Missed consensus by 32.4% - EPS $0.3182 vs $0.471 estimate

Q3-2008: Missed consensus by 32.4% - EPS $31.8196 vs $47.0983 estimate

Missed consensus by 21.9% - EPS $31.5704 vs $40.4 estimate

Missed consensus by 909.5% - EPS $-28.55 vs $-2.828 estimate

Q1-2025: Missed consensus by 12.7% - EPS $-11.55 vs $-10.2515 estimate

Q2-2025: Missed consensus by 156.7% - EPS $-24.5 vs $-9.5445 estimate

Q3-2025: Beat consensus by 54.3% - EPS $-2.1 vs $-4.5955 estimate

Q4-2025: Missed consensus by 46.5% - EPS $0.04 vs $0.0748 estimate

Q4-2025: Beat consensus by 19.3% - EPS $0.12 vs $0.1006 estimate

Q1-2026: Beat consensus by 16.5% - EPS $0.14 vs $0.1202 estimate

Q4-2025: Missed consensus by 24.0% - EPS $0.08 vs $0.1053 estimate

Q2-2025: Beat consensus by 73.8% - EPS $0.11 vs $0.0633 estimate

Q3-2025: Beat consensus by 27.8% - EPS $0.09 vs $0.0704 estimate

Q4-2026: Missed consensus by 15.4% - EPS $16.228 vs $19.1817 estimate

Q1-2026: Beat consensus by 19.5% - EPS $30.77018 vs $25.7399 estimate

Q3-2026: Beat consensus by 31.7% - EPS $34.92271 vs $26.5155 estimate

Beat consensus by 10.5% - EPS $31.79129 vs $28.78 estimate

Q4-2022: Beat consensus by 143.5% - EPS $1.5 vs $0.6161 estimate

Q2-2020: Missed consensus by 22.8% - EPS $0.6 vs $0.7777 estimate

Q4-2025: Missed consensus by 17.8% - EPS $2.4 vs $2.9189 estimate

Q1-2026: Beat consensus by 7.3% - EPS $5.16 vs $4.8088 estimate

Q4-2025: Beat consensus by 21.5% - EPS $0.75 vs $0.6171 estimate

Q2-2025: Beat consensus by 100.0% - EPS $0.95 vs $0.4751 estimate

Q3-2025: Beat consensus by 36.1% - EPS $0.68 vs $0.4996 estimate

Q3-2025: Beat consensus by 9.1% - EPS $-0.7 vs $-0.7701 estimate

Q2-2025: Beat consensus by 264.5% - EPS $0.26 vs $-0.1581 estimate

Q4-2025: Beat consensus by 30.7% - EPS $-0.41 vs $-0.5916 estimate

Q4-2025: Beat consensus by 11.7% - EPS $0.82 vs $0.7341 estimate

Q1-2026: Beat consensus by 19.1% - EPS $1.52 vs $1.2766 estimate

Q4-2025: Beat consensus by 5.1% - EPS $1.73 vs $1.6456 estimate

Q1-2026: Beat consensus by 5.9% - EPS $1.81 vs $1.7092 estimate

Q4-2025: Beat consensus by 2474.4% - EPS $1.56 vs $-0.0657 estimate

Q3-2025: Beat consensus by 10.0% - EPS $1.17 vs $1.0637 estimate

Q1-2026: Beat consensus by 5.1% - EPS $1.3 vs $1.2368 estimate

Q4-2025: Beat consensus by 8.7% - EPS $1.47 vs $1.3525 estimate

Q4-2025: Beat consensus by 15.6% - EPS $-0.29 vs $-0.3434 estimate

Q2-2025: Beat consensus by 16.4% - EPS $-0.3 vs $-0.3587 estimate

Beat consensus by 20.8% - EPS $-0.35 vs $-0.442 estimate

Q2-2025: Missed consensus by 39.7% - EPS $-0.78 vs $-0.5585 estimate

Q3-2025: Beat consensus by 30.6% - EPS $-0.37 vs $-0.5329 estimate